At CFO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top District of Columbia based CFO’ operating in the Health Care space. If you think a CFO’ is missing from this list, feel free to contact our editor on [email protected].
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Tim Schaller
Chief Financial Officer of New Enterprise Associates
Tim Schaller joined NEA in 2008 as Chief Financial Officer and is responsible for finance, investment operations, facilities, and information technology. Prior to joining NEA, Tim was Chief Financial Officer at Algenol Biofuels Inc., a Florida-based alternative energy company. He began his career at PricewaterhouseCoopers (C&L), where he was a Manager specializing in financial services. Tim earned his bachelor’s degree in accounting from Loyola College of Maryland and his master’s degree concentrating in financial management from Johns Hopkins University.
Follow Tim Schaller:
About New Enterprise Associates: New Enterprise Associates is a global venture capital firm investing in technology and healthcare.
Dane Saglio
CFO of Helomics
Dane Saglio serves as Chief Financial Officer of Helomics®. Formerly, Mr. Saglio was the CFO of RegeneRx Biopharmaceuticals, Inc; SuperNova Diagnostics; New Generation Biofuels; EntreMed Biopharmaceuticals; and held senior financial positions with Sterling Software, Inc. and Public Communication Associates. Mr. Saglio also has extensive public and private company experience along with a wide range of corporate finance and strategic transactions experience. Dane earned his B.S. in business administration from the University of Maryland and is a licensed CPA (inactive).
Follow Dane Saglio:
About Helomics, RegeneRx: Helomics provides comprehensive tumor profiling utilizing proprietary tissue-based live cell and fixed cell products and services.
Laurie Silver
Chief Financial Officer of BrainScope Company
Laurie Silver has over 20 years’ experience with a financial, accounting, strategic planning and operations background. Prior to BrainScope, she served as Director of Mergers and Acquisitions for the Services group at Symantec, where she led the integration of the Services organizations upon the $13 billion merger of Symantec and Veritas, which was the largest software company merger in history. Prior to Symantec, Ms. Silver was the Vice President of Finance and Administration of TrueCareers, a subsidiary of Sallie Mae; Manager of Financial Planning and Analysis across all business units of ABC/Disney; and a Senior Auditor at Ernst & Young LLP in New York. Ms. Silver graduated from the Stephen M. Ross School of Business at the University of Michigan and earned a CPA license from the State of New York. She has been with BrainScope since 2009.
Follow Laurie Silver:
About BrainScope Company: Brainscope is a medical neurotechnology company that improves brain health.
Richard Lindahl
Executive Vice President & Chief Financial Officer of Emergent BioSolutions
Rich Lindahl currently serves as the executive vice president and chief financial officer at Emergent BioSolutions.
Follow Richard Lindahl:
About Corporate Executive Board (CEB), Emergent BioSolutions: Emergent BioSolutions develops, manufactures, and delivers a portfolio of medical countermeasures for biological and chemical threats.
Douglas J. Swirsky
Chief Financial Officer of AavantiBio
Follow Douglas J. Swirsky:
About AavantiBio, TrAMPoline Pharma: AavantiBio is a biopharmaceutical company that provides gene transfer and gene editing therapies to treat genetic diseases.
Raymond Bryan
Chief Financial Officer and Chief Administrative Officer of The American Chemistry Council (ACC)
As CFO and Chief Administrative Officer of the American Chemistry Council (ACC), Mr. O’Bryan oversees the Accounting and Finance, Human Resources, Information Technology, Economic and Statistics and CHEMTREC® Divisions. These groups provide strategic planning, information management and back-office administrative services that support the Council’s programs, enhance advocacy and provide member value. Additionally, he serves as Plan Administrator for all pension and welfare benefit plans sponsored by the Council. Mr. O’Bryan joined the Council in 1985 as Assistant Controller and progressed up the Council’s management ranks, becoming ACC’s Vice President and Treasurer in 1998. He has nearly 30 years of experience in the financial management and reporting arenas, with 25 years here at ACC. Prior to coming to ACC, Ray held positions as an internal auditor with DynCorp. and in public accounting with a Washington, D.C.-based public accounting firm specializing in not-for-profit organizations. He is a member of the American Institute of Certified Public Accountants and the Greater Washington Society of CPA’s. Mr. O’Bryan received his bachelor’s degree in accounting from the University of South Carolina.
Follow Raymond Bryan:
About The American Chemistry Council (ACC): The American Chemistry Council (ACC) represents the leading companies in the business of chemistry.
Corbin Director
CFO of RxAnte
Prior to joining RxAnte, Mr. Director was a venture capitalist at Radius Ventures where he concentrated on executing development and growth stage investments in the healthcare information technology, healthcare services, and medical technology sectors. He was also previously an investment banker at B.C. Ziegler & Co. where he specialized in healthcare M&A and private placement transactions. Mr. Director earned a BA in Physical Science from Colgate University and an MBA from the Wharton School at the University of Pennsylvania.
Follow Corbin Director:
About RxAnte: RxAnte offers predictive analytics and targeted clinical programs that improve medication prescribing and adherence.
Eric Booth
Chief Financial Officer of Heart Rhythm Society
Follow Eric Booth:
About Heart Rhythm Society: Heart Rhythm Society provides professional programs and education to develop healthcare policies and patient care.